CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 vs ElucidVivo A.3
AI Verdict
Choose CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 if…
Choose CARTO™ 3 EP Navigation System Software V8.0 if your practice focuses on the diagnosis and treatment of complex cardiac arrhythmias. This system is ideal for electrophysiologists requiring advanced 3D cardiac mapping, precise catheter navigation, and AI-powered signal analysis to perform efficient and accurate catheter ablations for conditions like AFib and VT. It streamlines workflow with features like automated anatomical mapping and enhanced data validation.
View CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if your primary need is detailed, quantitative analysis of arterial plaque composition from CT angiography to better manage atherosclerosis patients. This tool is best suited for cardiologists, radiologists, and vascular surgeons who require AI-powered insights into plaque stability, lipid-rich necrotic core, and calcifications to stratify patient risk and optimize treatment strategies. It provides critical information for personalized cardiovascular care.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 | ElucidVivo A.3 |
|---|---|---|
| Deployment | On-premise (system with specialized hardware) | Cloud and on-premise secure deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CARTO 3 EP Navigation System Software V8.0 (FG-5400-00Tool A emphasizes features like 'streamlined workflow' and 'automatic catheter recognition' which are designed to enhance real-time procedural efficiency and ease of use in a high-stakes interventional setting. This focus on practical application during complex procedures gives it a slight edge in operational usability.
Clinical Value
ElucidVivo A.3While both offer significant clinical value, Tool B's explicit mention of validation against histology and the derivation of fractional flow reserve (FFRct) provides strong, objective measures of its clinical impact. These features offer foundational diagnostic insights for atherosclerosis patient stratification and treatment optimization, influencing broader patient management pathways.
Pricing & Value
TieBoth tools state 'contact for pricing' and do not provide publicly available pricing details. Without any transparent cost information or comparative value analyses, it is impossible to distinguish their pricing and overall value propositions.
Enterprise Readiness
CARTO 3 EP Navigation System Software V8.0 (FG-5400-00Tool A explicitly states 'yes' for BAA and HIPAA compliance for its associated cloud platform (CARTONETu2122) and provides a clear deployment model for EP labs. This level of documented compliance and defined deployment offers greater assurance for enterprise adoption compared to Tool B's implied compliance and less detailed deployment information.
Innovation
TieBoth tools demonstrate significant innovation by applying AI in distinct and impactful ways within cardiology. Tool A leverages AI for real-time 3D cardiac mapping, navigation, and signal analysis during procedures, while Tool B innovates in non-invasive, histology-validated diagnostic imaging and risk stratification by quantifying plaque composition and deriving FFRct. Both are pushing technological boundaries in their respective domains.
Support & Docs
CARTO 3 EP Navigation System Software V8.0 (FG-5400-00As part of Johnson & Johnson MedTech, Biosense Webster (Tool A) offers a more extensive and publicly documented support ecosystem, including dedicated Training Expertise Centers, comprehensive site visit programs, and detailed Instructions for Use. The availability of a structured support system for its associated cloud platform (CARTONETu2122) is also evident.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 | ElucidVivo A.3 |
|---|---|---|
| Name | CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00 | ElucidVivo A.3 |
| Company | Biosense Webster, Inc. | Elucid Bioimaging |
| Description | The CARTOu2122 3 EP Navigation System Software V8.0 by Biosense Webster is an FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders like AFib and VT. | ElucidVivo A.3 by Elucid Bioimaging is an FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology. |
| Key Features | Advanced Catheter Location (ACL) technology for accurate catheter visualization, Fast Anatomical Mapping (FAM) for rapid, high-resolution 3D cardiac maps, Connection of Choice for streamlined workflow and automatic catheter recognition, CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis and substrate characterization, CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation, Enhanced CONFIDENSEu2122 Module for optimized map creation and data validation, LAT Velocity Vectors for visualizing activation wave velocity over substrate maps, Stability+ algorithm for continuous analysis of ablation catheter movement. | AI-powered quantitative analysis of arterial plaque, Objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, Visualizes lesion-level plaque composition, Provides 3D visualization of highlighted vessels, Offers rotatable curved MPR vessel views and cross-sections, Aids in stratifying patients with atherosclerosis, Derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity, Validated on ground-truth histology. |
| Specialties | Cardiology | Cardiology, Radiology, Vascular Surgery |
| Categories | Cardiology AI, Surgical AI | Cardiology AI, Radiology & Imaging AI |
Videos
Demos, reviews, and walkthroughs featuring CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 and ElucidVivo A.3.